Serum biomarker panels for diagnosis of gastric cancer

OncoTargets and Therapy

Volumn 9, Issue , 2016, Pages 2455-2463

  Tong, Weihua ^a   Ye, Fei ^b   He, Liang ^a   Cui, Lifeng ^a   Cui, Miao ^b   Hu, Yuan ^b   Li, Wei ^a   Jiang, Jing ^a   Zhang, David Y ^b   Suo, Jian ^a  

^a JILIN UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer diagnosis; Cancer screening; Gastric adenocarcinoma; Luminex

Indexed keywords

A DISINTEGRIN AND METALLOPROTEINASE DOMAIN CONTAINING PROTEIN 8; ADAM PROTEIN; BETA CATENIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; HEMOGLOBIN; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; PEPSINOGEN I; PEPSINOGEN II; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ALGORITHM; AREA UNDER THE CURVE; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMACH ADENOCARCINOMA;

EID: 84964475888     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S86139     Document Type: Article

References (33)

1. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 [webpage on the Internet]. Lyon: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed June 14, 2015.
2. Chinese Cancer Registry Report. The Military Publishing House, China; 2013.
3. Cancer Stat Fact Sheets [webpage on the Internet]. Bethesda: National Cancer Institute. Available from: http://seer.cancer.gov/statfacts/. Accessed April 4, 2015.
4. Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer. 2014;17:26-33.
5. Pectasides D, Mylonakis A, Kostopoulou M, et al. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma. Am J Clin Oncol. 1997;20: 348-353.
6. Fan B, Xiong B. Investigation of serum tumor markers in the diagnosis of gastric cancer. Hepatogastroenterology. 2011;58:239-245.
7. Lin LL, Huang HC, Juan HF. Discovery of biomarkers for gastric cancer: a proteomics approach. J Proteomics. 2012;75:3081-3097.
8. Wu HH, Lin WC, Tsai KW. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med. 2014;16:e1.
9. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077-3079.
10. Li W, Ye F, Wang D, et al. Protein predictive signatures for lymph node metastasis of gastric cancer. Int J Cancer. 2013;132:1851-1859.
11. Wang D, Ye F, Sun Y, et al. Protein signatures for classification and prognosis of gastric cancer a signaling pathway-based approach. Am J Pathol. 2011;179:1657-1666.
12. Kudo T, Kakizaki S, Sohara N, et al. Analysis of ABC (D) stratification for screening patients with gastric cancer. World J Gastroenterol. 2011;17: 4793-4798.
13. Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9: 279-287.
14. Cao XY, Jia ZF, Jin MS, et al. Serum pepsinogen II is a better diagnostic marker in gastric cancer. World J Gastroenterol. 2012;18:7357-7361.
15. Barh D, Carpi A, Verma M, Gunduz M, editors. Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis. CRC Press, Taylor & Francis Group; 2014.
16. IARC. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to humans, Lyon, 7-14. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241.
17. Malfertheiner P, Sipponen P, Naumann M, et al. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol. 2005;100:2100-2115.
18. Kim SS, Ruiz VE, Carroll JD, Moss SF. Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett. 2011; 305:228-238.
19. Lamb A, Chen LF. Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer. J Cell Biochem. 2013; 114:491-497.
20. Jung WC, Jang YJ, Kim JH, et al. Expression of intercellular adhesion molecule-1 and e-selectin in gastric cancer and their clinical significance. J Gastric Cancer. 2012;12:140-148.
21. Nakata B, Hori T, Sunami T, et al. Clinical significance of serum soluble intercellular adhesion molecule 1 in gastric cancer. Clin Cancer Res. 2000; 6:1175-1179.
22. Alexiou D, Karayiannakis AJ, Syrigos KN, et al. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients. Am J Gastroenterol. 2003;98:478-485.
23. Liu L, Ma XL, Xiao ZL, Li M, Cheng SH, Wei YQ. Prognostic value of vascular endothelial growth factor expression in resected gastric cancer. Asian Pac J Cancer Prev. 2012;13:3089-3097.
24. Zhao R, Liu XG, Wu XP, et al. Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin alpha(v) beta6. Cancer Lett. 2010;287:150-156.
25. Jung DH, Lee HJ, Han DS, et al. Impact of perioperative hemoglobin levels on postoperative outcomes in gastric cancer surgery. Gastric Cancer. 2012;16:377-382.
26. Terashima M, Kitada K, Ochiai A, et al. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res. 2012;18:5992-6000.
27. Luminex. The xMAP® Cookbook, 2nd Edition. Austin: Luminex. Available from: http://info2.luminexcorp.com/download-the-xmap-cookbook. Accessed April 4, 2015.
28. Westgard JO, Barry PL, Hunt MR, Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem. 1981;27: 493-501.
29. Breiman L. Random Forests. Mach Learn. 2001;45:5-32.
30. Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics. 2000;16:906-914.
31. Cui L, Zhang X, Ye G, et al. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer. 2013;119: 1618-1626.
32. Liu HS, Xiao HS. MicroRNAs as potential biomarkers for gastric cancer. World J Gastroenterol. 2014;20:12007-12017.
33. Xu ZQ, Broza YY, Ionsecu R, et al. A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions. Br J Cancer. 2013;108:941-950.